US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
オーストラリア
ASX
Global Lithium Resources Limited (GL1) 銘柄情報

Global Lithium Resources Limited (GL1)

0.50

-0.01

(-1.96%)

終了 6月7日 3:00PM

Global Lithium Resources Limited (GL1) 銘柄情報

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

通貨

0.50

( -1.96% )

買値

0.50

売値

0.525

出来高

164,836

0.495 日の範囲 0.54

0.135 52 週間の範囲 0.695

時価総額

前日終値

0.51

始値

0.51

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

AUD 277,164

発行済株式数

262,962,123

配当利回り

PER

-1.24k

1 株当たり利益 (EPS)

-0

歳入

2.43M

純利益

-40.25k

Global Lithium Resources Limited engages in the evaluation, exploration, and development of lithium resources in Australia. The company primarily holds 100% interests in the Manna lithium project located in the Goldfields region, Western Australia; and the Marble Bar lithium project situated in the ... Global Lithium Resources Limited engages in the evaluation, exploration, and development of lithium resources in Australia. The company primarily holds 100% interests in the Manna lithium project located in the Goldfields region, Western Australia; and the Marble Bar lithium project situated in the Pilbara region, Western Australia. Global Lithium Resources Limited was incorporated in 2018 and is based in West Perth, Australia. 詳細を表示

セクター

Materials

業界

Mining

ウェブサイト

globallithium.com.au

本社

West Perth, Australia

設立

2026

Global Lithium Resources Limited is listed in the Materials sector of the オーストラリア証券取引所 with ticker GL1. The last closing price for Global Lithium Resources was AUD0.51. Over the last year, Global Lithium Resources shares have traded in a share price range of AUD 0.135 to AUD 0.695.

Global Lithium Resources currently has 262,962,123 shares in issue. The market capitalisation of Global Lithium Resources is AUD131.48 million. Global Lithium Resources has a price to earnings ratio (PE ratio) of -1,241.13.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-0.01	-1.96078431373	0.51	0.55	0.495	153937	0.52110033	DE
4	-0.08	-13.7931034483	0.58	0.595	0.48	219855	0.5286959	DE
12	-0.005	-0.990099009901	0.505	0.625	0.455	271592	0.54170914	DE
26	-0.13	-20.6349206349	0.63	0.695	0.44	375295	0.55754492	DE
52	0.35	233.333333333	0.15	0.695	0.135	462333	0.45823422	DE
156	-1.04	-67.5324675325	1.54	1.91	0.135	490656	0.67451796	DE
260	0.235	88.679245283	0.265	2.94	0.135	727349	1.12131893	DE

GL1 - Frequently Asked Questions (FAQ)

What is the current Global Lithium Resources Limited share price?

The current share price of Global Lithium Resources Limited is AUD 0.50

How many Global Lithium Resources Limited shares are in issue?

Global Lithium Resources Limited has 262,962,123 shares in issue

What is the market cap of Global Lithium Resources Limited?

The market capitalisation of Global Lithium Resources Limited is AUD 131.48M

What is the 1 year trading range for Global Lithium Resources Limited share price?

Global Lithium Resources Limited has traded in the range of AUD 0.135 to AUD 0.695 during the past year

What is the PE ratio of Global Lithium Resources Limited?

The price to earnings ratio of Global Lithium Resources Limited is -1.24k

What is the cash to sales ratio of Global Lithium Resources Limited?

The cash to sales ratio of Global Lithium Resources Limited is 56.82

What is the registered address of Global Lithium Resources Limited?

The registered address for Global Lithium Resources Limited is 16 Ventnor Avenue, West Perth, Western Australia, 6005

What is the Global Lithium Resources Limited website address?

The website address for Global Lithium Resources Limited is globallithium.com.au

Which industry sector does Global Lithium Resources Limited operate in?

Global Lithium Resources Limited operates in the Mining sector

DewDiligence

DewDiligence 3分前

ABT dual glucose/ketone CGMs facilitate_early_detection_of diabetic ketoacidosis (DKA):

https://www.prnewswire.com/news-releases/new-abbott-data-show-many-people-with-diabetes-may-not-recognize-symptoms-of-diabetic-ketoacidosis-302793024.html Findings from multiple Abbott studies sha

jour_trader

jour_trader 3分前

Would certainly be astronomical, just don’t think the odds are in our favor. We’ll know soon enough via lawsuit or cc if paragraph IV was pursued.

DewDiligence

DewDiligence 3分前

ABT dual glucose/ketone CGMs facilitate_early_detection_of diabetic ketoacidosis (DKA):

https://www.prnewswire.com/news-releases/new-abbott-data-show-many-people-with-diabetes-may-not-recognize-symptoms-of-diabetic-ketoacidosis-302793024.html Findings from multiple Abbott studies sha

JamesF1

JamesF1 4分前

I look at the possibility of Elite successfully getting a paragraph 4 approval for Eliquis as a long shot. Long shots occasionally come in.

DewDiligence

DewDiligence 4分前

FDA approval of ABT's dual glucose/ketone CGMs is coming soon; the products are already approved in Europe.

1plus1

https://www.theguardian.com/football/2026/jun/06/mexico-security-world-cup-fan-zone-growing-protests-football >> LET'S HOPE THEY MENTION THE CO.

camelion

camelion 8分前

June flowers 💐!

Flobewan

Flobewan 8分前

Hey, somebody ate all my homemade banana cream ice cream, not only that but they ate all my chocolate/banana cream combo graham cracker crust pie. Now I gotta make more ice cream. Gonna see how chocolate/banana cream ice cream comes out.

And somehow my whole loaf of homemade bread dis

manibiotech

manibiotech 9分前

NICE has always said that they are Liaising with NWBO for years . Sommer is know what’s different that you are claiming ?

US Market News

US Market News 9分前

Dexcom CONNECT Study: The Most Significant Clinical Study Demonstrating CGM Benefits for People with Type 2 Diabetes Not Using InsulinJune 6, 2026 2:45 PM
Business Wire Dexcom sponsored CONNECT randomized controlled trial expected to help establish new

joe botts

joe botts 10分前

Sorry 6' 1 here! Lol!!!!!!!

manibiotech

manibiotech 10分前

Agreed

If they wanted privacy and silence they should have stayed private and not took public money to pay their salaries and development and denied any accountability to the same public ( aka shareholders )

1plus1

1plus1 10分前

world cup starts in days >> biei /security should be involved >>https://www.fifa.com/en/tournaments/mens/worldcup/canadamexicousa2026/mexico/mexico-city

jimr1717

jimr1717 11分前

Has updated timeline 39Z-4 been updated?

researcher59

researcher59 13分前

SPCX - retail shares are not restricted, but Fidelity may limit access to futures IPOs for those who flip their shares in under 15 days.

The IPO may be oversubscribed, so if you ask for 50 shares you might only get 25.

https://www.businessinsider.com/spacex-ipo-fidelity

JimmyRich

JimmyRich 13分前

🙏🏼🙏🏼🙏🏼 my friend

bbotcs

bbotcs 13分前

INTU is near its 52-week low. If the perception among hedge fund managers and other institutional investors is that AI is going to hurt Intuit, it is going to stay down, imo.
The company needs a strong AI strategy.
Also, the dividend yield is not good. IMO, investors are not getting

Doc logic

Doc logic 15分前

brazen22,

That is certainly one way of thinking. I personally don’t have a problem with that but there still remains the bigger picture to consider. In my view “the process” and the framework it is built on is the problem creating this kind of dilemma that all parties are required t

walterc

walterc 16分前

th6565. what is your nationality?

jimr1717

jimr1717 18分前

“Although Wertheim & Co. no longer exists as an independent entity” ❌

Only Fools are Fooled

https://wertheimandcompany.com/transactions/

Top Penny

Top Penny 19分前

Why not? Because you are short and nobody can make coin except you? Try again because you lose here pal!!!

Top Penny

Top Penny 20分前

Within in the next 30 days IMO, soon trips are history for good!!!

Top Penny

Top Penny 20分前

Lve

What do you think the price will go to?

joe botts

joe botts 22分前

Global Lithium Resources

Agf Global Yield Fund Se...

Equity Idx Lkd Nts 07/11...

RSE Archive (GM)

Electro Sensors

Charter Hall Long WALE R...

iShares Morningstar Smal...

Amundi MSCI Emerging Mar...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。